Hamilton Lane appoints Michael Schmertzler independent director to board - HLNE News | RalliesHamilton Lane appoints Michael Schmertzler independent director to board
H
HLNE• Hamilton Lane appoints Michael Schmertzler to board
- Hamilton Lane elected Michael Schmertzler as an independent director, effective July 22, 2026.
- Schmertzler becomes the fifth independent director, joining three executive directors on the board.
- He is chairman and a director at PTC Therapeutics.
- He previously served as a managing director at Credit Suisse First Boston Equity Partners, including as investment committee chair.
- Earlier roles included managing director at Morgan Stanley, including president of Morgan Stanley Leveraged Capital Funds.
•
